Skip Navigation



Carcinogenesis Advance Access published online on January 23, 2004

Carcinogenesis, doi:10.1093/carcin/bgh095
© 2004 by Oxford University Press
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
25/6/987    most recent
bgh095v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Vayalil, P. K.
Right arrow Articles by Katiyar, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vayalil, P. K.
Right arrow Articles by Katiyar, S. K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION

Proanthocyanidins from grape seeds inhibit expression of matrix metalloproteinases in human prostate carcinoma cells which is associated with the inhibition of activation of MAPK and NF{kappa}B

Praveen K. Vayalil 1, Anshu Mittal 1, and Santosh K. Katiyar 2*

1 Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294
2 Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294; Department of Environmental Health Sciences, University of Alabama at Birmingham, Birmingham, AL 35294; Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35294

* Corresponding author. E-mail: skatiyar{at}uab.edu.

Received 11 November 2003 ; revised 22 December 2003 ; accepted 14 January 2004

Abstract

Prostate cancer (PCA) is the second most frequently diagnosed and leading cause of cancer-related deaths in men in the USA. The recognition that matrix metalloproteinases (MMPs) facilitate tumor cell invasion and metastasis of PCA has led to the development of MMP inhibitors as cancer therapeutic agents. As part of our efforts to develop newer and effective chemopreventive agents for PCA, we evaluated the effect of proanthocyanidins from grape seeds (GSP) on metastasis-specific MMP-2 and -9 in human prostate carcinoma DU145 cells by employing Western blot and gelatinolytic zymography. Treatment of GSP dose-dependently inhibited cell proliferation (15-100% by 5-80µg/ml of GSP), viability (30-80% by 20-80 µg/ml of GSP) and fibroblast conditioned medium (FCM)-induced expression of MMP-2 and -9 in DU145 cells. Since the signaling cascade of mitogen-activated protein kinases (MAPK) have been shown to regulate the expression of MMPs in tumor cells, we found that the treatment of DU145 cells with GSP (20-80 µg/ml) resulted in marked inhibition of FCM-induced phosphorylation of ERK1/2 and p38 but had little effect on JNK under similar experimental conditions. GSP treatment (20-80 µg/ml) to DU145 cells also dosedependently inhibited FCM-induced activation of NF{kappa}B concomitantly inhibition of MMP-2 and MMP-9 expression in the same system. Additionally, the treatment of inhibitors of MEK (PD98059) and p38 (SB203580) to DU145 cells resulted in reduction of FCM-induced phosphorylation of ERK1/2 and p38 concomitantly marked reduction in MMP-2 and -9 expressions. In further studies, treatment of androgen-sensitive LNCaP cells with a synthetic androgen R1881 resulted in an increase of MMP-2 and -9, which were completely abrogated in the presence of GSP (20-60µg/ml). These data suggest that inhibition of metastasis-specific MMPs in tumor cells by GSP is associated with the inhibition of activation of MAPK and NF{kappa}B pathways, and thus providing the molecular basis for the development of GSP as a novel chemopreventive agent for both androgen-sensitive and -insensitive prostate cancer therapies.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Anticancer ResHome page
S. EVANS, N. DIZEYI, P.-A. ABRAHAMSSON, and J. PERSSON
The Effect of a Novel Botanical Agent TBS-101 on Invasive Prostate Cancer in Animal Models
Anticancer Res, October 1, 2009; 29(10): 3917 - 3924.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. M. Meeran, M. Vaid, T. Punathil, and S. K. Katiyar
Dietary grape seed proanthocyanidins inhibit 12-O-tetradecanoyl phorbol-13-acetate-caused skin tumor promotion in 7,12-dimethylbenz[a]anthracene-initiated mouse skin, which is associated with the inhibition of inflammatory responses
Carcinogenesis, March 1, 2009; 30(3): 520 - 528.
[Abstract] [Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
K. Chatelain, S. Phippen, J. McCabe, C. A. Teeters, S. O'Malley, and K. Kingsley
Cranberry and Grape Seed Extracts Inhibit the Proliferative Phenotype of Oral Squamous Cell Carcinomas
Evid. Based Complement. Altern. Med., July 23, 2008; (2008) nen047v1.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. C. Neto
Cranberry and Its Phytochemicals: A Review of In Vitro Anticancer Studies
J. Nutr., January 1, 2007; 137(1): 186S - 193S.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. K. Mantena, M. S. Baliga, and S. K. Katiyar
Grape seed proanthocyanidins induce apoptosis and inhibit metastasis of highly metastatic breast carcinoma cells
Carcinogenesis, August 1, 2006; 27(8): 1682 - 1691.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. Veluri, R. P. Singh, Z. Liu, J. A. Thompson, R. Agarwal, and C. Agarwal
Fractionation of grape seed extract and identification of gallic acid as one of the major active constituents causing growth inhibition and apoptotic death of DU145 human prostate carcinoma cells
Carcinogenesis, July 1, 2006; 27(7): 1445 - 1453.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.